Butane

Butane

SCHEMBL7388669

BrCCC(c1ccccc1)c1ccccc1.CCCC

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.52
HRH1 P35367 8/20 0.48
HTR2A P28223 8/20 0.48
CYP3A4 P08684 2/20 0.44
LMNA P02545 2/20 0.44
HTR1A P08908 2/20 0.44
ADORA3 P0DMS8 2/20 0.44
SLC6A2 P23975 2/20 0.44
SLC6A4 P31645 2/20 0.44
ADRA1A P35348 2/20 0.44
OPRM1 P35372 2/20 0.44
DRD3 P35462 2/20 0.44
SLC6A3 Q01959 2/20 0.44
KCNH2 Q12809 2/20 0.44
CHRM2 P08172 1/20 0.44
ADRA2A P08913 1/20 0.44
CHRM1 P11229 1/20 0.44
SMPD1 P17405 1/20 0.44
DRD1 P21728 1/20 0.44
TBXA2R P21731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2172475 0.91 HRH1 (0.56) SIGMAR1HRH1HTR2ACYP3A4LMNA
SCHEMBL30171026 0.88 HRH1 (0.54) SIGMAR1HRH1HTR2ACYP3A4LMNA
SCHEMBL107889 0.80 HRH1 (0.56) SIGMAR1HRH1HTR2ACYP3A4LMNA
SCHEMBL30312009 0.78 AOC3 (0.42) SIGMAR1HRH1HTR2ALMNAOPRM1
SCHEMBL6702276 0.78 CYP19A1 (0.49) SIGMAR1HRH1HTR2ALMNASLC6A4
Hydrochloric Acid SCHEMBL6521685 0.78 HRH1 (0.54) SIGMAR1HRH1HTR2ACYP3A4LMNA
SCHEMBL28229621 0.78 HRH1 (0.54) SIGMAR1HRH1HTR2ACYP3A4LMNA
Ammonia Solution, Strong SCHEMBL5724927 0.78 HRH1 (0.54) SIGMAR1HRH1HTR2ACYP3A4LMNA
Hydrogen Peroxide SCHEMBL27864054 0.78 HRH1 (0.54) SIGMAR1HRH1HTR2ACYP3A4LMNA
Butane SCHEMBL16459462 0.77 SIGMAR1 (0.57) SIGMAR1HRH1HTR2ACYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6054448-A TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM. ELI LILLY AND COMPANY LIMITED (GB) 2000-04-25 US disclosed
EP-0837061-A1 Pharmaceutical acidic compounds ELI LILLY AND COMPANY LIMITED (GB) 1998-04-22 EP disclosed